MULTIPLE THERAPIES, ONE VIRUS.
KALIVIR is developing cutting-edge, next-generation oncolytic viral immunotherapy programs for treatment of cancer.
PRESENTATIONS
READ MORE
Dec 13, 2022 – KaliVir Immunotherapeutics Establishes Clinical and Scientific Advisory Boards
READ MORE
NEWS AND EVENTS
Novel Vaccinia Enhanced Template (VET) Oncolytic Platform LEARN MORE
